Patent application number | Description | Published |
20100178551 | Galvanic Element, and Methods for the Production of Galvanic Elements - The invention relates to galvanic elements comprising two electrodes on at least one support and at least one electrolyte in at least some areas between the electrodes. Also disclosed are methods for producing galvanic elements. Said galvanic elements comprising at least one support, two electrodes, and at least one electrolyte in at least some areas between the electrodes as well as the methods for producing galvanic elements are characterized particularly by the simple structure thereof and can be produced economically. For this purpose, at least one area of a plate-shaped body encompassing introduced openings is disposed between the electrodes as a separator. Alternatively, at least one area of a layer or of an object that is used as a receptacle can be disposed between the electrodes, subareas of the support, or one of the electrodes and a subarea of the support. The support comprising the electrodes is tilted, folded, seamed, bent, or turned over in such a way that the electrodes point in the direction of the and the electrolyte. | 07-15-2010 |
20110253789 | IDENTIFICATION SYSTEM AND APPLICATIONS - The invention relates to an identification system, comprising an information carrier or a group of such information carriers, which allow a clear association of information. The invention further relates to the use of said information carriers, and to a device for reading said information carriers, wherein the information carriers are associated with a random action of a data processing system by way of the structured information layer thereof or can trigger such action. The invention furthermore relates to information carriers for access control systems, payment systems, ticket systems, and marketing application. According to the invention, overlaps of the information layer can be provided by applying additional layers, which achieve several advantages according to the invention, such as optically rendering the information layer unrecognizable, and resulting increased safety of the information carrier against manipulation. In addition, the information layers can be applied in an absolutely level and thin manner onto the carrier material, which enables unlimited further processing. | 10-20-2011 |
20120125993 | PLANAR DATA CARRIER - The invention relates to a data carrier or a group of such data carriers which allow for accurate correlation of information, the use of these data carriers, as well as a reading device, by means of which a data carrier via its structured information layer is associated with an action of a data processing system or can trigger the said action. More particularly, the invention also relates to a game card system that learns the unique playing characteristics of players and allows the processing of other game-related data, whereby the system comprises the use of game cards and collector cards over the Internet (online) as well as via a local data processing system (offline), and where, accordingly, the invention relates to a particularly preferred embodiment, that is a combination of the traditional collector card game with computer and video games. More preferably, the invention also serves as an access system for cards and debit cards for payment systems using the data carrier with a unique code that is readable using a reading device. | 05-24-2012 |
20120306813 | SYSTEM AND METHOD FOR RETRIEVING INFORMATION FROM AN INFORMATION CARRIER BY MEANS OF A CAPACITIVE TOUCH SCREEN - The present invention relates to a method comprising providing one or more information carrier(s) with a dielectric and/or conductive pattern and a detection device having a capacitive touch screen and inducing an interaction between the information carrier and the touch screen, wherein the interaction is based on a difference in the dielectric coefficient and/or the conductivity of the pattern and generates a touch signal and wherein the interaction is induced by relative motion between the information carrier and the touch screen. The invention further relates to a system comprising an information carrier comprising a dielectric and/or conductive pattern which encodes information and a detection device having a touch screen; the detection device is able to decode the information upon interaction between the information carrier and the touch screen, wherein the interaction is caused by a difference in the dielectric coefficient and/or the conductivity of the pattern. | 12-06-2012 |
20130115878 | SYSTEM COMPRISING A CAPACITIVE INFORMATION CARRIER FOR ACQUIRING INFORMATION - The invention describes a system comprising a capacitive information carrier, wherein an electrically conductive layer is arranged on an electrically non-conductive substrate, and a surface sensor, wherein the information carrier is in contact with the surface sensor. Furthermore, the invention comprises a process for acquiring information, comprising a capacitive information carrier, a capacitive surface sensor, a contact between the two elements and an interaction which makes a touch structure of the information carrier evaluable for a data-processing system connected to the surface sensor and can trigger events associated with said information carrier. | 05-09-2013 |
20130221089 | ELECTROLYTE-CONTAINING INFORMATION CARRIER - The invention describes and information carrier comprising an electrically non-conductive substrate to which an electrolyte is applied to certain regions. | 08-29-2013 |
20130256419 | MULTIPLE INFORMATION CARRIER - The invention describes a multiple information carrier having at least one electrically conductive layer and an electorally non-conductive substrate, wherein at least one first electrically conductive layer in the form of a touch structure, and second electrically conductive layer in the form of an antenna, are present in places on the substrate. | 10-03-2013 |
20130284578 | INFORMATION CARRIER AND SYSTEM FOR ACQUIRING INFORMATION - The invention describes a capacitive information carrier in which at least one electrically conductive touch structure is arranged on an electrically non-conductive substrate. The invention also comprises a system and method for acquiring information, consisting of a capacitive information carrier, a capacitive area sensor, a contact between the two elements and interaction which makes the touch structure of the information carrier evaluable for a data processing system connected to the area sensor and can trigger events associated with the information carrier. | 10-31-2013 |
20140111469 | System And Method For Retrieving Information From An Information Carrier By Means Of A Capacitive Touch Screen - The present invention relates to a method comprising providing one or more information carrier(s) with a dielectric and/or conductive pattern and a detection device having a capacitive touch screen and inducing an interaction between the information carrier and the touch screen, wherein the interaction is based on a difference in the dielectric coefficient and/or the conductivity of the pattern and generates a touch signal and wherein the interaction is induced by relative motion between the information carrier and the touch screen. The invention further relates to a system comprising an information carrier comprising a dielectric and/or conductive pattern which encodes information and a detection device having a touch screen; the detection device is able to decode the information upon interaction between the information carrier and the touch screen, wherein the interaction is caused by a difference in the dielectric coefficient and/or the conductivity of the pattern. | 04-24-2014 |
20140198062 | Input Element for Operating a Touch-Screen - There is described an input element for operating a touch-screen, said input element comprising an electrically conductive layer which is applied to an electrically non-conductive substrate. The electrically conductive layer is structured and has at least one button, conductor track and/or electrode, wherein at least one electrode and/or conductor track is operatively connected to the touch-screen. | 07-17-2014 |
20140332587 | Identification System and Applications - The invention relates to an identification system, comprising an information carrier or a group of such information carriers, which allow a clear association of information. The invention further relates to the use of said information carriers, and to a device for reading said information carriers, wherein the information carriers are associated with a random action of a data processing system by way of the structured information layer thereof or can trigger such action. The invention furthermore relates to information carriers for access control systems, payment systems, ticket systems, and marketing application. According to the invention, overlaps of the information layer can be provided by applying additional layers, which achieve several advantages according to the invention, such as optically rendering the information layer unrecognizable, and resulting increased safety of the information carrier against manipulation. In addition, the information layers can be applied in an absolutely level and thin manner onto the carrier material, which enables unlimited further processing. | 11-13-2014 |
20140354594 | TOUCH-SENSITIVE DATA CARRIER AND METHOD - The invention relates to a system for triggering at least one touch event on a resistive and/or capacitive input interface. The system comprises at least one layer of an electrically nonconductive medium, and contact surfaces are present on the medium as geometric shapes and/or lines, said medium being in contact with the input interface. | 12-04-2014 |
20150199039 | INPUT MEANS FOR A TOUCHSCREEN - In some embodiments, an input means is provided, comprising an electrically nonconductive substrate, an electrically conductive area that is present on the substrate, an electrical conductor track, a control unit for electrically interconnecting the electrical areas and an energy source. In some embodiments, a system is provided, comprising an input means and a touchscreen. | 07-16-2015 |
20150236754 | MEANS FOR TRANSMITTING DATA IN A UNIDIRECTIONAL OR BIDIRECTIONAL MANNER - In some embodiments, a system is provided for transmitting data between a device having a touch screen and a transmitting and/or receiving device. The touch screen may be a capacitive screen and the device may have at least one plate having at least one electrically conductive area, wherein the plate is operatively connected to the touch screen and at least one area is activated. | 08-20-2015 |
Patent application number | Description | Published |
20090109645 | Power Semiconductor Module Comprising Load Connection Elements Applied To Circuit Carriers - A power semiconductor module is disclosed including a housing for receiving at least one essentially board-type circuit carrier, the circuit carrier being provided with a metallization on at least one part of its surface and being populated with and electrically connected to at least one power semiconductor, rigid, integral and essentially straight load connection elements being applied on the metallized part of the metallized surface of the circuit carrier, which load connection elements are electrically and mechanically fixedly connected to the circuit carrier by one of their ends and project essentially perpendicularly into the housing interior, separate connection terminal elements for electrical conduct-making being placed onto the free end of the load connection elements. | 04-30-2009 |
20100309633 | ELECTRONIC CIRCUIT COMPOSED OF SUB-CIRCUITS AND METHOD FOR PRODUCING THE SAME - To improve manufacture of an electronic circuit, the electronic circuit is composed of modules of sub-circuits arranged on a common substrate, such as a cooling body, and that are electrically interconnected by a planar electrical contact element. | 12-09-2010 |
20130118869 | SWITCHING DEVICE WITH A HEAT EXTRACTION APPARATUS - A switching device is disclosed, in particular a circuit breaker, with a thermal release, on which a moving switching piece is arranged by a contact link support. The moving switching piece is borne on a spring body and is arranged opposite stationary switching pieces. A heat-extraction apparatus composed of a heat-dissipating material is in each case arranged at the side, along the stationary switching pieces. | 05-16-2013 |
20140332502 | CIRCUIT BREAKER COMPRISING VENTILATION CHANNELS FOR EFFICIENT HEAT DISSIPATION - A circuit breaker includes a housing equipped with a first switchgear region, in which a quenching chamber device and a sliding contact device having movable contacts are located, the contacts lying opposite fixed contacts, and equipped with a second switchgear region, in which a current release assembly consisting of a short-circuit release and an overload release are located. In an embodiment, a continuous ventilation channel is formed within opposing housing walls along the fixed contacts, the channel acting as a first convective air-flow through the circuit breaker in order to dissipate the heat. | 11-13-2014 |
Patent application number | Description | Published |
20080233651 | Method and medicament for inhibiting the expression of a given gene - The present invention relates to the specific inhibition of expression of a target gene in mammals using a short double stranded RNA. The dsRNA is less than 49 nucleotides in length and has a nucleotide sequence which is complementary to at least a part of the target gene. The dsRNAs of the present invention are useful for treating diseases, for example, cancer, viral diseases or neurodegenerative diseases. | 09-25-2008 |
20080261303 | Method and medicament for inhibiting the expression of a given gene - The present invention relates to the specific inhibition of expression of a target gene in mammals using a short double stranded RNA. The dsRNA is less than 49 nucleotides in length and has a nucleotide sequence which is complementary to at least a part of the target gene. The dsRNAs of the present invention are useful for treating diseases, for example, cancer, viral diseases or neurodegenerative diseases. | 10-23-2008 |
20100291194 | Compositions and Methods for Inhibiting Expression of a Mutant Gene - The present invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of a mutant gene, comprising a complementary RNA strand having a complementary region that is substantially complementary to a portion of the mutant gene, and which is partially complementary to the corresponding wild-type gene. The invention further relates to a pharmaceutical composition comprising the dsRNA and a pharmaceutically acceptable carrier. The pharmaceutical compositions are useful for inhibiting the expression of a target mutant gene, as well as for treating diseases caused by expression of the target gene. The invention also relates to methods for inhibiting the expression of a target mutant gene, as well as methods for treating diseases caused by the expression of the target gene. | 11-18-2010 |
20100316699 | Compositions and Methods for Inhibiting Viral Replication - The present invention relates to a double-stranded ribonucleic acid (dsRNA) having a nucleotide sequence which is less that 30 nucleotides in length and which is substantially identical to at least a part of a 3′-untranslated region (3′-UTR) of a (+) strand RNA virus, such as HCV, as well as pharmaceutical compositions comprising the dsRNA, together with a pharmaceutically acceptable carrier. The pharmaceutical compositions are useful for treating infections and diseases caused by the replication or activity of the (+) strand RNA virus, as well as methods for inhibiting viral replication. | 12-16-2010 |
20110065777 | DOUBLE-STRANDED RNA (dsRNA) AND METHOD OF USE FOR INHIBITING EXPRESSION OF A FUSION GENE - Specific inhibition of expression of a fusion gene in mammals occurs using a short, double-stranded ribonucleic acid molecule (dsRNA). The dsRNA comprises two separate non-linked RNA strands, an 51 strand and a complementary strand. The strands are 20 to 23 nucleotides in length, and the 51 strand is complementary to the fusion junction of the AML-1/MTG-8 fusion gene. The dsRNA also comprises at least 3 nucleotides on each side of the fusion junction. The dsRNA can be introduced into and maintained in a mammalian cell under conditions and for a time sufficient to obtain degradation of mRNA of the fusion gene to inhibit expression of the fusion gene. The dsRNAs and methods described are useful for treating diseases caused by chromosomal aberrations, particularly malignant diseases such as lymphoma and leukemia. | 03-17-2011 |
20110111493 | Compositions and Methods For Inhibiting Expression Of A Target Gene - The present invention relates to a double-stranded ribonucleic acid (dsRNA) having a nucleotide sequence which is substantially identical to at least a part of a target gene and which is no more than 49, preferably less than 25, nucleotides in length, and which comprises a complementary (antisense) RNA strand having a 1 to 4 nucleotide overhang at the 3′-end and a blunt 5′-end. The invention further relates to a pharmaceutical composition comprising the dsRNA and a pharmaceutically acceptable carrier. The pharmaceutical compositions are useful for inhibiting the expression of a target gene, as well as for treating diseases caused by expression of the target gene, at low dosages (i.e., less than 5 milligrams, preferably less than 25 micrograms, per kg body weight per day). The invention also relates to methods for inhibiting the expression of a target gene, as well as methods for treating diseases caused by the expression of the gene. | 05-12-2011 |
20110207795 | SMAD7 INHIBITOR COMPOSITIONS AND USES THEREOF - The present invention relates to the use of a specific inhibitor of Smad7 expression or function for the preparation of a pharmaceutical composition for the prevention, amelioration or treatment of a disease of the central nervous system and/or diseases related and/or caused by said disease of the central nervous system. Furthermore, methods for preventing, ameliorating and/or treating such diseases are disclosed. | 08-25-2011 |
20110287090 | Compositions and Methods for Inhibiting Expression of a Mutant Gene - The present invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of a mutant gene, comprising a first strand that has a complementary region that is complementary to at least a portion of an RNA transcript of at least part of the mutant target gene and a second strand of the dsRNA complementary or substantially complementary to the first strand. The invention further relates to a pharmaceutical composition comprising the dsRNA and a pharmaceutically acceptable carrier. The pharmaceutical compositions are useful for inhibiting the expression of a target mutant gene, as well as for treating diseases caused by expression of the target gene. The invention also relates to methods for inhibiting the expression of a target mutant gene, as well as methods for treating diseases caused by the expression of the target gene. | 11-24-2011 |
20120322858 | Compositions and Methods for Inhibiting Expression of a Mutant Gene - The present invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of a mutant gene, comprising a first strand that has a complementary region that is complementary to at least a portion of an RNA transcript of at least part of the mutant target gene and a second strand of the dsRNA complementary or substantially complementary to the first strand. The invention further relates to a pharmaceutical composition comprising the dsRNA and a pharmaceutically acceptable carrier. The pharmaceutical compositions are useful for inhibiting the expression of a target mutant gene, as well as for treating diseases caused by expression of the target gene. The invention also relates to methods for inhibiting the expression of a target mutant gene, as well as methods for treating diseases caused by the expression of the target gene. | 12-20-2012 |
20130064879 | Compositions and Methods for Inhibiting Viral Replication - The present invention relates to a double-stranded ribonucleic acid (dsRNA) having a nucleotide sequence which is less that 30 nucleotides in length and which is substantially identical to at least a part of a 3′-untranslated region (3′-UTR) of a (+) strand RNA virus, such as HCV, as well as pharmaceutical compositions comprising the dsRNA, together with a pharmaceutically acceptable carrier. The pharmaceutical compositions are useful for treating infections and diseases caused by the replication or activity of the (+) strand RNA virus, as well as methods for inhibiting viral replication. | 03-14-2013 |
20130164366 | Method and medicament for inhibiting the expression of a given gene - The invention relates to an isolated RNA that mediates RNA interference of an mRNA to which it corresponds and a method of mediating RNA interference of mRNA of a gene in a cell or organism using the isolated RNA. | 06-27-2013 |
20130164843 | Method and medicament for inhibiting the expression of a given gene - The invention relates to an isolated RNA that mediates RNA interference of an mRNA to which it corresponds and a method of mediating RNA interference of mRNA of a gene in a cell or organism using the isolated RNA. | 06-27-2013 |
20130177631 | Method and medicament for inhibiting the expression of a given gene - The invention relates to an oligoribonucleotide of double-stranded structure (dsRNA) for inhibiting the expression of a given target gene in mammalian cells and a method of mediating RNA interference of an mRNA of a gene in mammalian cells using the dsRNA. | 07-11-2013 |
20140051166 | Method and medicament for inhibiting the expression of a given gene - The invention relates to an isolated RNA that mediates RNA interference of an mRNA to which it corresponds and a method of mediating RNA interference of mRNA of a gene in a cell or organism using the isolated RNA. | 02-20-2014 |
20140106450 | Compositions and Methods for Inhibiting Expression of a Target Gene - The present invention relates to a double-stranded ribonucleic acid (dsRNA) having a nucleotide sequence which is substantially identical to at least a part of a target gene and which is no more than 49, preferably less than 25, nucleotides in length, and which comprises a complementary (antisense) RNA strand having a 1 to 4 nucleotide overhang at the 3′-end and a blunt 5′-end. The invention further relates to a pharmaceutical composition comprising the dsRNA and a pharmaceutically acceptable carrier. The pharmaceutical compositions are useful for inhibiting the expression of a target gene, as well as for treating diseases caused by expression of the target gene, at low dosages (i.e., less than 5 milligrams, preferably less than 25 micrograms, per kg body weight per day). The invention also relates to methods for inhibiting the expression of a target gene, as well as methods for treating diseases caused by the expression of the gene. | 04-17-2014 |
20140220113 | Method and Medicament for Inhibiting the Expression of a Given Gene - The invention relates to an isolated RNA that mediates RNA interference of an mRNA to which it corresponds and a method of mediating RNA interference of mRNA of a gene in a cell or organism using the isolated RNA. | 08-07-2014 |
20140220676 | Method and Medicament for Inhibiting the Expression of a Given Gene - The invention relates to an isolated RNA that mediates RNA interference of an mRNA to which it corresponds and a method of mediating RNA interference of mRNA of a gene in a cell or organism using the isolated RNA. | 08-07-2014 |
20150353937 | Compositions and Methods for Inhibiting Expression of a Target Gene - The present invention relates to a double-stranded ribonucleic acid (dsRNA) having a nucleotide sequence which is substantially identical to at least a part of a target gene and which is no more than 49, preferably less than 25, nucleotides in length, and which comprises a complementary (antisense) RNA strand having a 1 to 4 nucleotide overhang at the 3′-end and a blunt 5′-end. The invention further relates to a pharmaceutical composition comprising the dsRNA and a pharmaceutically acceptable carrier. The pharmaceutical compositions are useful for inhibiting the expression of a target gene, as well as for treating diseases caused by expression of the target gene, at low dosages (i.e., less than 5 milligrams, preferably less than 25 micrograms, per kg body weight per day). The invention also relates to methods for inhibiting the expression of a target gene, as well as methods for treating diseases caused by the expression of the gene. | 12-10-2015 |